INNOVATION HALL IS NOW OPEN!Check it out
INNOVATION HALL IS NOW OPEN!

[Innovation Hall Event] Valuing Drugs: Biopharma, Profit, and Patients | Saint Louis University Bander Center for Medical Business Ethics

STAY CONNECTED

Subscribe to our once-a-week email to see what talks are coming up and other important Venture Café updates.

Subscribe
by Christina Celuzza
January 23, 2017
When:
February 21, 2019 @ 4:00 pm – 6:00 pm
2019-02-21T16:00:00-06:00
2019-02-21T18:00:00-06:00
Where:
Innovation Hall STL
4220 Duncan Ave
St. Louis, MO 63110
USA
[Innovation Hall Event] Valuing Drugs:  Biopharma, Profit, and Patients | Saint Louis University Bander Center for Medical Business Ethics @ Innovation Hall STL  | St. Louis | Missouri | United States

A Discussion with Steven Miller, MD (Chief Medical Officer, Express-Scripts)
Moderated by Anthony Mikulec, MD

What should drugs be priced, especially when their development is often subsidized by United States taxpayers? Should pharmaceutical companies be obligated to maximize their profits? How much is too much? Should healthcare providers consider price when it comes to
prescribing drugs for patients? Join us for a Bander Center Signature Event on February 21 at 4:00 PM in the brand-new Innovation Hall at 4220 Duncan Avenue. Bander Center Director, Tony Mikulec, MD, MBA, FACS will interview Express Scripts Chief Medical Officer, Steven Miller, MD about contemporary social and ethical issues in drug pricing. The event will be followed by an open bar networking reception Dr. Steve Miller, a nationally recognized advocate for fair drug pricing, supports government relations, leads the Pharmacy & Therapeutics Committee, manages the Medical Affairs team and interfaces with client groups. His expertise represents years as a medical researcher, clinician and administrator, and spans numerous healthcare subjects.

Steve has served as Chief Medical Officer since 2006, focused on clinical matters including e-prescribing initiatives, specialty solutions and overall development of products that make prescription drugs safer and more affordable. He previously was the vice president and chief medical officer at Barnes-Jewish Hospital, Washington University School of Medicine in St. Louis. He received his medical degree from the University of Missouri-Kansas City. He trained in the Pathology and Research fellowship at the University of Alabama at Birmingham. He was the William J. and Dorothy Fish Kerr Fellow in Cardiology at the University of California, San Francisco. Steve also did Internal Medicine training at the University of Colorado and Nephrology and Transplantation at Washington University in St. Louis. He earned his MBA at the Olin School of Business at Washington University.

Anthony Mikulec MD, MBA is a tenured Professor in the Saint Louis University Department of
Otolaryngology where he serves as the Director of the Division of Otology, Neurotology and
Skull Base Surgery and the Director of Faculty of the Bander Center for Medical Business
Ethics. He completed his residency in Otolaryngology at Stanford University in 2002 and a
fellowship in Neurotology and Skull Base Surgery at Harvard University and the Massachusetts Eye and Ear Infirmary in 2004. He specializes in all aspects of adult and pediatric ear and skull base surgery with a focus on inner ear drug delivery. He has been the recipient of extramural clinical and basic science research grants and served on the steering committee of an international clinical trial. He also has an interest in entrepreneurship and the business of medicine and has been a member of the Billiken Angels Network.

 

INFO:

Thursday, February 21 at 4:00 PM

Open Bar Reception to Follow

Innovation Hall – Assembly, First Floor

 

STAY CONNECTED

Subscribe to our once-a-week email to see what talks are coming up and other important Venture Café updates.

Subscribe